![1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide](https://img.chemicalbook.in/ProductImageIndia/2024-03/Large/76d12285-a869-474c-afdd-a000aadd0eff.png)
59729-32-7 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide 98%
| Price | Get Latest Price | ||||
| Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2023-09-15
Product Details
- Product Name1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide
- CAS No.59729-32-7
- EINECS No.261-890-6
- MFC20H22BrFN2O
- MW405.3
- AppearancepowderWhite
- Melting point 182-188°C
- storage temp. 2-8°C
Company Profile Introduction
we are specialty chemicals and
intermediates manufacturers, also can do CRO.
Supplier other products
![S-(+)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate](/ProductImageIndia/2024-03/Large/349de44d-af3d-46bd-9f4c-def49f31471c.png)
Recommended supplier
-
VIP1年
- Raks Pharma Pvt Ltd
- 59729-32-7 99%
- Inquiry
- 2024-03-27
-
VIP1年
- Vijaya Pharma And Life Science
- 59729-32-7 Citalopram hydrobromide 98%
- Inquiry
- 2024-03-13
-
VIP0年
- Glyra Health Care Pvt Ltd
- Citalopram hydrobromide 99%
- Inquiry
- 2024-02-21
-
VIP1年
- Ralington Pharma
- 59729-32-7 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Raising Sun Pharma
- 59729-32-7 Citalopram hydrobromide 98%
- Inquiry
- 2024-02-03
-
VIP1年
- Kekule Pharma Limited
- Citalopram hydrobromide 59729-32-7 98%
- Inquiry
- 2024-01-31
-
VIP1年
- Rivashaa Agrotech Biopharma Pvt. Ltd.
- Citalopram hydrobromide 98%
- Inquiry
- 2024-01-25
-
VIP1年
- Valentis Laboratories Pvt. Ltd.
- 59729-32-7 98%
- Inquiry
- 2024-01-22
-
VIP1年
- Synergene Active Ingredients Pvt. Ltd.
- 59729-32-7 Citalopram hydrobromide 98%
- Inquiry
- 2024-01-17
-
VIP1年
- Aruvi Labs
- Citalopram hydrobromide 59729-32-7 98%
- Inquiry
- 2024-01-16
- Since:2020-09-01
- Address: No. R-116, K.S.S.I.D.C. Industrial Estate, Hebbal, Mysore, Mysuru-570016, Karnataka, India
INQUIRY